Immune Thrombocytopenia

Immune Thrombocytopenia is an autoimmune bleeding disorder in which the immune system mistakenly attacks and destroys platelets, the blood cells responsible for clotting, leading to an abnormally low platelet count. This deficiency increases the risk of easy bruising and bleeding, ranging from minor skin spots to serious internal bleeding in severe cases. The condition can occur in both children, often following a viral infection with spontaneous resolution, and adults, where it tends to follow a more chronic course. Its severity varies widely between individuals.

The most common symptoms include: Easy or excessive bruising; tiny red or purple spots on the skin (petechiae); bleeding gums; nosebleeds. Early recognition is key to prompt diagnosis and effective treatment.

No, Immune Thrombocytopenia is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: Mild cases with no significant bleeding may only require monitoring; while more severe cases are treated with corticosteroids to suppress the immune attack; intravenous immunoglobulin for rapid platelet increase. Treatment should always be guided by a qualified Hematology specialist. Do not self-medicate.

While Immune Thrombocytopenia cannot always be fully prevented, several measures can reduce risk: No known prevention; but avoiding medications that increase bleeding risk when platelet counts are low; prompt treatment of triggering infections.

Consult a Hematology specialist if symptoms persist for more than a few days, worsen despite home care, or significantly affect your daily activities. Early diagnosis leads to better outcomes.